ES2041641T3 - Granulos que contienen vitaminas y procedimientos para su produccion. - Google Patents
Granulos que contienen vitaminas y procedimientos para su produccion.Info
- Publication number
- ES2041641T3 ES2041641T3 ES198686307598T ES86307598T ES2041641T3 ES 2041641 T3 ES2041641 T3 ES 2041641T3 ES 198686307598 T ES198686307598 T ES 198686307598T ES 86307598 T ES86307598 T ES 86307598T ES 2041641 T3 ES2041641 T3 ES 2041641T3
- Authority
- ES
- Spain
- Prior art keywords
- sub
- granules
- vitamin
- compounds
- powders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pyridine Compounds (AREA)
Abstract
PUEDE PREPARARSE UN GRANULO QUE CONTIENE VITAMINA Y QUE COMPRENDE SUSTANCIALMENTE UNO O MAS COMPUESTOS SELECCIONADOS DEL GRUPO QUE CONSISTE EN VITAMINAS B6 Y B2, NICOTINAMIDA Y UNA SAL DEL ACIDO PANTOTENICO Y UN AGENTE AGLOMERANTE, CONSTITUYENDO DICHO COMPUESTO U COMPUESTOS DEL 90 AL 99% EN PESO EN SECO, APLICANDO A LOS POLVOS DE DICHO COMPUESTO O COMPUESTOS UN RECUBRIMIENTO POR PULVERIZACION DE UNA SOLUCION QUE CONTIENE UN AGLOMERANTE, MIENTRAS SE MANTIENEN LOS POLVOS EN ESTADO FLUIDIFICADO EN UN APARATO DE GRANULACION EN LECHO FLUIDIFICADOS. SUS GRANULOS SON MUY FLUIDOS Y SE MEZCLAN BIEN CON OTROS MEDICAMENTOS, GRANULOS, ADITIVOS, ETC. ADEMAS, LOS GRANULOS SE COMPRIMEN MUY BIEN, POR LO QUE PUEDEN TRANSFORMARSE EN TABLETAS CON POCO EXCIPIENTE Y ESTAS SON DE UNA DUREZA SATISFACTORIAMENTE ALTA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22407985 | 1985-10-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2041641T3 true ES2041641T3 (es) | 1993-12-01 |
Family
ID=16808227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES198686307598T Expired - Lifetime ES2041641T3 (es) | 1985-10-07 | 1986-10-02 | Granulos que contienen vitaminas y procedimientos para su produccion. |
Country Status (11)
Country | Link |
---|---|
US (1) | US4868180A (es) |
EP (1) | EP0219276B1 (es) |
JP (1) | JPH0751504B2 (es) |
KR (1) | KR930008951B1 (es) |
CN (1) | CN1022024C (es) |
AT (1) | ATE77942T1 (es) |
AU (1) | AU587863B2 (es) |
CA (1) | CA1308024C (es) |
DE (1) | DE3685927T2 (es) |
DK (1) | DK167339B1 (es) |
ES (1) | ES2041641T3 (es) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2689458B2 (ja) * | 1988-02-09 | 1997-12-10 | 武田薬品工業株式会社 | 粒状ないし粉末状のビタミンb▲下1▼▲下2▼類含有組成物 |
LU87145A1 (fr) * | 1988-02-26 | 1989-09-20 | Oreal | Methode pour ameliorer l'aspect esthetique de la peau a l'aide de melanges polyvitaminiques |
ATE99545T1 (de) * | 1989-03-29 | 1994-01-15 | Takeda Chemical Industries Ltd | Zusammensetzung mit einer verbindung der vitamin b-gruppe und ihre herstellung. |
JP2591235B2 (ja) * | 1989-03-30 | 1997-03-19 | 吉富製薬株式会社 | アルキルシステインまたはその酸付加塩を含有する安定な錠剤 |
US5034389A (en) * | 1989-07-28 | 1991-07-23 | Coors Biotech, Inc. | Riboflavin composition and method for production |
DE3927810A1 (de) * | 1989-08-23 | 1991-02-28 | Basf Ag | Riboflavingranulate |
GB8922701D0 (en) * | 1989-10-09 | 1989-11-22 | Leung Lit Hung | Compositions and methods for weight reduction |
US5254551A (en) * | 1990-04-30 | 1993-10-19 | Kirk Paula S | Flour fortification formulation comprising granulated riboflavin |
US4994458A (en) * | 1990-04-30 | 1991-02-19 | Basf Corporation | Process for rotary fluid bed granulation of riboflavin |
US5236920A (en) * | 1990-04-30 | 1993-08-17 | Basf Corporation | Granulated riboflavin product having high flowability, high riboflavin content |
DE4014262A1 (de) * | 1990-05-04 | 1991-11-07 | Basf Ag | Gut rieselfaehige, nichtstaubende bindemittelfreie riboflavinspruehgranulate oder -mikrogranulate aus reinem riboflavin und ein verfahren zu deren herstellung |
US5000888A (en) * | 1990-05-23 | 1991-03-19 | Basf Corporation | Process for spray drying riboflavin to produce a granulate product having low binder content |
JP3011752B2 (ja) * | 1990-10-23 | 2000-02-21 | フロイント産業株式会社 | 徐放性製剤およびその製造方法 |
GB2252905B (en) * | 1991-02-11 | 1995-05-10 | Leung Lit Hung | An agent for correcting a deficiency of androgenic steroids |
GB2252729B (en) * | 1991-02-13 | 1994-11-09 | Bharat Sridhar Pancham | Vitamin and/or mineral containing pharmaceutical compositions |
NZ244270A (en) * | 1991-09-13 | 1995-07-26 | Eisai Co Ltd | Injectable composition comprising riboflavin |
WO1993013756A1 (en) * | 1992-01-10 | 1993-07-22 | Obschestvo S Ogranichennoy Otvetstvennostyu Meditsinsky Nauchno-Proizvodstvennoy Komplex 'biotiki' | Granulated pharmaceutical composition and method of obtaining it |
SE9303574D0 (sv) * | 1993-11-01 | 1993-11-01 | Kabi Pharmacia Ab | Composition for drug delivery and method the manufacturing thereof |
US5635535A (en) * | 1996-04-05 | 1997-06-03 | Wagstaff; Robert K. | Method for increasing blood glucose levels |
JP4098376B2 (ja) * | 1996-09-05 | 2008-06-11 | ビーエーエスエフ ソシエタス・ヨーロピア | 錠剤特性の優れた水溶性ビタミン組成物およびその製造法 |
US6093715A (en) * | 1999-03-24 | 2000-07-25 | Basf Aktiengesellschaft | Process for producing riboflavin-containing granules |
JP2001031567A (ja) * | 1999-05-20 | 2001-02-06 | Takeda Chem Ind Ltd | アスコルビン酸塩含有組成物 |
DE10032349A1 (de) | 2000-07-04 | 2002-01-17 | Degussa | Rieselfähige D-Pantothensäure und/oder deren Salze enthaltende Futtermittel-Additive und Verfahren zu deren Herstellung |
IT1320776B1 (it) * | 2000-08-07 | 2003-12-10 | Giampiero Valletta | Composizione farmaceutica a base di un'associazione vitaminica per laterapia delle cefalee primarie |
US6773733B2 (en) | 2001-03-26 | 2004-08-10 | Loders Croklaan Usa Llc | Structured particulate systems |
JP2005501833A (ja) * | 2001-07-30 | 2005-01-20 | ディーエスエム アイピー アセッツ ビー.ブイ. | エピガロカテキンガレートのための組成物 |
JP4519444B2 (ja) * | 2003-10-31 | 2010-08-04 | ライオン株式会社 | 口腔内崩壊錠 |
CA2589200A1 (en) * | 2004-11-26 | 2006-06-01 | Medicure International Inc. | Formulations of pyridoxal -5'-phosphate and methods of preparation |
FR2879403B1 (fr) * | 2004-12-20 | 2007-05-11 | Alept Sarl Soc | Complement alimentaire destine a prevenir l'apparition des symptomes associes a la maladie d'alzheimer |
JP5198001B2 (ja) * | 2006-06-23 | 2013-05-15 | 武田薬品工業株式会社 | 安定化された固形製剤 |
EP2042164A4 (en) * | 2006-06-23 | 2010-10-13 | Takeda Pharmaceutical | STABILIZED SOLID PREPARATION |
CA2899225A1 (en) | 2007-07-06 | 2009-01-15 | Basf Se | Method for the production of an aqueous glucose solution |
DE102007045038A1 (de) * | 2007-09-13 | 2009-03-19 | MEDICE Arzneimittel Pütter GmbH & Co. KG | Arzneimittel zur Behandlung oder Prävention von Proteinurie |
CN101632648A (zh) * | 2008-07-23 | 2010-01-27 | Ss制药株式会社 | 薄膜包衣制剂 |
MX351356B (es) * | 2008-11-13 | 2017-10-04 | Com S Car Borr S A De C V | Kit de formulaciones farmaceuticas caracterizado por la presencia de oxigeno molecular. |
JP5584534B2 (ja) * | 2009-06-30 | 2014-09-03 | 興和株式会社 | 安定化方法 |
JP5897916B2 (ja) * | 2012-01-31 | 2016-04-06 | アサヒフードアンドヘルスケア株式会社 | ビタミン含有錠剤及びその製造方法 |
TW201402153A (zh) * | 2012-04-04 | 2014-01-16 | Lonza Ag | 菸鹼醯胺粉末和其製備方法及裝置 |
US9510617B2 (en) | 2012-04-13 | 2016-12-06 | Frito-Lay North America, Inc. | Micropellets of fine particle nutrients and methods of incorporating same into snack food products |
US9271523B2 (en) | 2012-05-23 | 2016-03-01 | Dennis Williams | Rotor assembly with one-piece finger member |
CN103720660A (zh) * | 2013-11-19 | 2014-04-16 | 华中药业股份有限公司 | 一种核黄素颗粒及其制备方法 |
JP6056064B2 (ja) * | 2013-11-29 | 2017-01-11 | 国立大学法人 東京大学 | 卵殻膜成分を含むインスリン抵抗性改善剤ならびにそれを用いた組成物 |
CN105581982A (zh) * | 2014-10-23 | 2016-05-18 | 华中药业股份有限公司 | 一种烟酰胺颗粒剂及其制备方法 |
CN111012748B (zh) * | 2018-10-10 | 2022-06-10 | 常州市第四制药厂有限公司 | 维生素b12制剂及其制备方法 |
WO2020093192A1 (zh) * | 2018-11-05 | 2020-05-14 | 重庆小丸科贸有限公司 | 一种水溶性活性物颗粒及其制备方法和应用 |
CN109771383A (zh) * | 2018-12-20 | 2019-05-21 | 华中药业股份有限公司 | 复合维生素b颗粒、复合维生素b片及其制备方法 |
US20220280462A1 (en) * | 2019-08-26 | 2022-09-08 | Dsm Ip Assets B.V. | Solid oral dosage form comprising naproxen and vitamin b1 |
CN111012755A (zh) * | 2020-01-09 | 2020-04-17 | 仁和堂药业有限公司 | 维生素b6片的制备工艺 |
CN111110643A (zh) * | 2020-01-09 | 2020-05-08 | 仁和堂药业有限公司 | 一种维生素b6片剂及其质量检测方法 |
CN111419808A (zh) * | 2020-04-23 | 2020-07-17 | 河南海汇药物研究有限公司 | 一种维生素b6全粉末压片工艺 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA678143A (en) * | 1964-01-14 | Hochberg Melvin | Tablets for pharmaceutical use | |
US3308217A (en) * | 1965-02-09 | 1967-03-07 | Lowy Lawrence | Method of granulating materials for subsequent forming into tablets |
US3493659A (en) * | 1967-10-23 | 1970-02-03 | Hoffmann La Roche | Compositions and process for the production thereof |
BE791458A (fr) * | 1972-07-31 | 1973-05-16 | Merck & Co Inc | Produit microencapsule |
ZA739543B (en) * | 1973-02-16 | 1975-03-26 | Hoffmann La Roche | Free-flowing, directly tablettable, pharmaceutically active substances |
JPS58403B2 (ja) * | 1975-07-24 | 1983-01-06 | 武田薬品工業株式会社 | L− アスコルビンサンセイザイノ セイゾウホウ |
JPS5759803A (en) * | 1980-09-30 | 1982-04-10 | Takeda Chem Ind Ltd | Granule of l-sodium ascorbate, its preparation, and tablet comprising it |
EP0125252A1 (de) * | 1982-11-16 | 1984-11-21 | MOTSCHAN, Georges | Neue verwendung eines einzelnen vitamins oder einer kombination verschiedener vitamine |
US4486435A (en) * | 1983-05-16 | 1984-12-04 | Basf Wyandotte Corporation | Spray-dried vitamin powders using hydrophobic silica |
JPS6143108A (ja) * | 1984-08-03 | 1986-03-01 | Nippon Shinyaku Co Ltd | 医薬品製剤及びその製造法 |
JPH0753663B2 (ja) * | 1984-10-09 | 1995-06-07 | 武田薬品工業株式会社 | チアミン塩の顆粒,その製造法および錠剤 |
-
1986
- 1986-09-18 AU AU62919/86A patent/AU587863B2/en not_active Expired
- 1986-09-26 DK DK459486A patent/DK167339B1/da not_active IP Right Cessation
- 1986-10-01 US US06/915,125 patent/US4868180A/en not_active Expired - Lifetime
- 1986-10-01 CA CA000519504A patent/CA1308024C/en not_active Expired - Lifetime
- 1986-10-02 DE DE8686307598T patent/DE3685927T2/de not_active Expired - Lifetime
- 1986-10-02 AT AT86307598T patent/ATE77942T1/de not_active IP Right Cessation
- 1986-10-02 ES ES198686307598T patent/ES2041641T3/es not_active Expired - Lifetime
- 1986-10-02 KR KR1019860008291A patent/KR930008951B1/ko not_active IP Right Cessation
- 1986-10-02 EP EP86307598A patent/EP0219276B1/en not_active Expired - Lifetime
- 1986-10-03 JP JP61236793A patent/JPH0751504B2/ja not_active Expired - Lifetime
- 1986-10-06 CN CN86106839A patent/CN1022024C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH0751504B2 (ja) | 1995-06-05 |
ATE77942T1 (de) | 1992-07-15 |
DK167339B1 (da) | 1993-10-18 |
KR930008951B1 (ko) | 1993-09-17 |
EP0219276A3 (en) | 1988-09-21 |
CN1022024C (zh) | 1993-09-08 |
JPS62174013A (ja) | 1987-07-30 |
DE3685927T2 (de) | 1992-12-24 |
KR870003776A (ko) | 1987-05-04 |
CN86106839A (zh) | 1988-04-20 |
US4868180A (en) | 1989-09-19 |
DK459486A (da) | 1987-04-08 |
AU6291986A (en) | 1987-04-09 |
AU587863B2 (en) | 1989-08-31 |
CA1308024C (en) | 1992-09-29 |
EP0219276A2 (en) | 1987-04-22 |
DE3685927D1 (de) | 1992-08-13 |
DK459486D0 (da) | 1986-09-26 |
EP0219276B1 (en) | 1992-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2041641T3 (es) | Granulos que contienen vitaminas y procedimientos para su produccion. | |
DK163208C (da) | Retard-praeparat af acemetacin og fremgangsmaade til fremstilling deraf | |
JPS55153715A (en) | Prolonged granule of theophylline | |
JPS5215812A (en) | Process for preparing an l-ascorbic acid pharmaceutical | |
DK616186D0 (da) | Farmaceutisk praeparat med retarderet frigivelse af ibuprofen | |
ZA200306614B (en) | Method to obtain microparticles containing a H +, K + -ATP-ase inhibitor. | |
MY100900A (en) | Substituted phenylsulfonyloxybenzimidazolecarbamates, processes for their preparation and their use as medicaments. | |
US3950546A (en) | Pulverulent vitamin and mineral-fortified clay product for farrowing house floor | |
JPS5489036A (en) | Remedy and preventive for hypersensitivity to light | |
ZA926536B (en) | Substituted mandelic acid derivatives, processes for their preparation and their use in medicaments. | |
CA2403110A1 (en) | N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them | |
ATE30231T1 (de) | 3-beta-(3'-(carboxypropionyloxy))-ursa-9(11),12 dien-28-carbonsaeure sowie ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
Ershoff | Protective effects of cholestyramine in rats fed a low-fiber diet containing toxic doses of sodium cyclamate or amaranth | |
AU553742B2 (en) | Antibiotic feed agent for coccidiosis | |
GB1478020A (en) | Composition for the treatment of asthma | |
JPS5325534A (en) | Mandelic acid glucosides and their anti-cancerous preparations | |
JPS539315A (en) | Preparation of hardly soluble pharmaceuticals | |
JPS57209222A (en) | Cardiac | |
JPS55133313A (en) | Cholesterol-lowering agent | |
JPS57109722A (en) | Antitumor agent containing deoxyfluorouridine benzyloxylated at 4-position | |
ES8302670A1 (es) | Procedimiento de preparacion de nuevos derivados 2-hidroxi- metil-quinoxalino-1,4-dioxidos | |
JPS5791914A (en) | Peptic unti-ulcer | |
Wahlstrom et al. | High-Protein Oats in Ground and Pelleted Pig Starter Diets | |
RU2002116760A (ru) | Способ производства гранулированных кормов для рыб | |
JPS54105237A (en) | Analgesic agent containing nalorphine-6-glucuronide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 219276 Country of ref document: ES |